Trending...
- Expanding Beyond Space as New Drone Market Opportunities Accelerate Growth: Ascent Solar Technologies (N A S D A Q: ASTI)
- Lauren Merrell, Dale Sorensen Real Estate, announces price improvement for an extraordinary island retreat
- Boston: Notice of Finding of No Significant Impact and Notice of Intent to Request Release of Funds - Hollins Park: August 7, 2026
FAYETTEVILLE, Ark. - BostonChron -- Lineus Medical, a leader in vascular access innovation and maker of SafeBreak® Vascular, the first breakaway device for IV lines, today announced the renewal of its agreement with Vizient, one of the nation's largest group purchasing organization (GPO). The renewed contract delivers more competitive pricing for Vizient members, expanding access to SafeBreak Vascular across health systems nationwide.
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on Boston Chron
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on Boston Chron
- KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
- Private Autopsies Give Arizona Families Answers After Nursing Home and Care Facility Deaths
- OPUS Global Data Solutions Launches Food Trader Plus, Bringing Operational Control and Deal-Level Profit Visibility to Food Brokers
- Phinge CEO DeMaio Unveils Speech to Congress: User Data Sovereignty vs Tech Surveillance Capitalism, Asserting Foundational 2021 App-Less Patents & IP
- Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
Source: Lineus Medical
Filed Under: Technology
0 Comments
Latest on Boston Chron
- ASSIST Software Becomes One of the First European Companies Certified to ISO/IEC 42001
- The World's No.1 Superstar® Enters the Occult with New Track and Cinematic Visual "Under Your Spell"
- PricZone Launches Online Shopping Platform Offering Electronics, Gaming, and More
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community
- Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
- Gateway Center Arena Announces Duane Curry as General Manger
- No Sugar Baker Continues National Growth
- XRPPower Expands Platform Security With Enhanced Brand Protection and Official Verification Standards
- Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
- RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
- International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
- The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
- City of Boston Announces 26th Annual Gospel Fest
- FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
- Boston: Notice of Finding of No Significant Impact and Notice of Intent to Request Release of Funds - Hollins Park: August 7, 2026
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
- Boston: Color Flows Honors History at Liberty Tree Plaza
- Boston: Archaeologists Unearth New Clues at the Battle of Bunker Hill Site
- Boston: A New Chapter for the Blackstone Block


